|
⚲
|
| Keyboard |
| Smith Michael David
✚
|
|
|---|---|
| CIK # | 0001867598, 0001777800 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001777800] | |
| 4 | [0001777800] | |
| 3 | [0001867598] | |
| 4 | [0001867598] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Proterra Inc | |
| Smith Michael David | |
| Smith Michael David | |
| KalVista Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Proterra Inc PTRAQ
Common Stock
|
2024-03-13 | Other | 32,422 | $0.00 | |
|
Proterra Inc PTRA
Common Stock
|
2023-03-28 | Grant | 33,407 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Restricted Stock Units · derivative
|
2022-05-17 | Grant | 15,480 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Employee Stock Option (Right to Buy) · derivative
|
2022-05-17 | Grant | 10,320 | $0.00 | |
|
Proterra Inc PTRA
Common Stock
|
2022-03-08 | Disposed to issuer | 8,812 | $7.39 | 65,121 |
|
Proterra Inc PTRA
Common Stock
|
2022-02-17 | Grant | 12,626 | $0.00 | |
|
Proterra Inc PTRA
Common Stock
|
2021-11-29 | Grant | 8,812 | $0.00 | |
|
Proterra Inc PTRA
Common Stock
|
2021-07-20 | Grant | 3,093 | $8.93 | 27,620 |
|
Proterra Inc PTRA
Stock Option (Right to Buy) · derivative
|
2021-06-14 | Grant | 200,812 | ||
|
Proterra Inc PTRA
Stock Option (Right to Buy) · derivative
|
2021-06-14 | Grant | 20,081 | ||
|
Proterra Inc PTRA
Stock Option (Right to Buy) · derivative
|
2021-06-14 | Grant | 44,625 | ||
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2021-06-01 | Sell | 7,500 | $26.83 | 201,225 |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2021-06-01 | Option exercise | 7,500 | $8.39 | 62,925 |
|
KalVista Pharmaceuticals Inc KALV
Stock Option (right to buy) · derivative
|
2021-06-01 | Option exercise | 7,500 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Employee Stock Option (Right to Buy) · derivative
|
2021-05-26 | Grant | 35,000 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2021-04-28 | Sell | 10,014 | $25.76 | 257,961 |
|
KalVista Pharmaceuticals Inc KALV
Stock Option (right to buy) · derivative
|
2021-04-28 | Option exercise | 10,014 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Common Stock
|
2021-04-28 | Option exercise | 10,014 | $8.39 | 84,017 |
|
KalVista Pharmaceuticals Inc KALV
Stock Option (right to buy) · derivative
|
2021-02-07 | Grant | 16,500 | $0.00 | |
|
KalVista Pharmaceuticals Inc KALV
Stock Option (right to buy) · derivative
|
2020-12-16 | Grant | 25,000 | $0.00 |